Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
146 hedge funds and large institutions have $897M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 22 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
44% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 41
29% more call options, than puts
Call options by funds: $576K | Put options by funds: $446K
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
7% more capital invested
Capital invested by funds: $839M → $897M (+$57.7M)
2% more funds holding
Funds holding: 143 → 146 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$47.9M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$33.2M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$22.8M |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$16.7M |
| 5 |
Goldman Sachs
New York
|
+$14.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wolverine Trading
Chicago,
Illinois
|
-$28.7M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$18.5M |
| 3 |
AC
Armistice Capital
New York
|
-$17.9M |
| 4 |
Millennium Management
New York
|
-$6.71M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.71M |
DCPH Hedge Fund Activity: Q1 2023 in Review
146 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q1 2023, worth a combined $897M — up 6.9% from $839M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new DCPH positions and 22 closed out — a net gain of 3 holders — while 59 added to existing stakes and 41 trimmed.
The largest buyer was Deerfield Management, adding an estimated $47.9M. The largest seller was Wolverine Trading, exiting entirely with an estimated $28.7M sold.
- 146 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q1 2023, up from 143 in Q4 2022.
- Funds reported $897M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q1 2023, up 6.9% quarter-over-quarter.
- 25 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q1 2023 and 22 closed out, a net change of +3 holders.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q1 2023 was Deerfield Management, an estimated $47.9M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q1 2023 was Wolverine Trading, an estimated $28.7M sold.
Based on aggregated 13F filings for Q1 2023.